Research Progress on Risk Factors of Brain Metastasis in Non-small Cell Lung Cancer
Brain metastasis of non-small cell lung cancer (NSCLC) is a common treatment failure mode, and the median survival time of NSCLC patients with brain metastasis is only 1 mon-2 mon. Prophylactic cranial irradiation (PCI) can delay the occurrence of brain metastasis, but the survival benefits of NSCLC...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Chinês |
| Cyhoeddwyd: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2022-03-01
|
| Cyfres: | Chinese Journal of Lung Cancer |
| Pynciau: | |
| Mynediad Ar-lein: | http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.08 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|